This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the
use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in
less respiratory depression while providing better compliance with the procedure.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pennsylvania
Collaborators:
Hospira, Inc. Hospira, now a wholly owned subsidiary of Pfizer